Skip to content

Clinical trials

Terminated Carcinoma, Hepatocellular trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Terminated Country / region: Hong Kong Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20081
20091
20101
20113
20121
20131
20182
20201
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong4
Abbott1
Astellas Pharma Inc1
Cellxpert Biotechnology Corp.1
FeRx1
Humanity & Health Medical Group Limited1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Omega Therapeutics1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular16
Liver Neoplasms5
Neoplasms3
Adenocarcinoma1
Carcinoma1
Digestive System Diseases1
Digestive System Neoplasms1
Liver Diseases1
Neoplasms by Histologic Type1
Neoplasms by Site1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.